Well, ummm the primary endpoints were missed, so not sure the results were "that good." I did not read the full article, but not sure what 3X benefit is...where was that referenced? I did not take the results to be "that good."
Nice...I guess I am a basher who caused the stock decline. I am very influential you know! Lol Not!! I guess the results were deemed to be consistent with my thoughts...not too good. Sucks to be right.
Basically, no statistical difference in complete clearance of blepharitis, although 10% of patients got complete clearance on Azasite plus, and 4% got complete clearance on durasite vehicle control. Why approve a drug if it clears 10% of patients? I hope they saw some massive improvements in other parameters because that is not impressive at all